Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,525.27
-21.9265-1.42%
Number of Gainers:3
Number of Losers:4
Number of Flat:- -
PE:- -
High:1,557.91
Open:1,547.24
Low:1,519.17
Close:1,547.20
Volume:102.64M
Turnover:6.83B
Market Cap:1.61T
Float Cap:1.53T

Loading ...

US names Eli Lilly, Pfizer and AbbVie drugs for next Medicare price talks

Reuters
·
1 hour ago

Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
1 hour ago

Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
1 hour ago

AstraZeneca PLC ADR Outperforms Competitors On Strong Trading Day

Dow Jones
·
1 hour ago

Insulet Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
1 hour ago

BRIEF-CMS Announces Selection Of Drugs For Third Cycle Of The Medicare Drug Price Negotiation Program

Reuters
·
2 hours ago

Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
2 hours ago

CMS: Drugs Selected for Third Cycle of Medicare Drug Price Negotiation Are Rexulti, Trulicity, Verzenio, Xeljanz; Xeljanz Xr and Xolair

THOMSON REUTERS
·
2 hours ago

Pfizer Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
2 hours ago

AbbVie Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
2 hours ago

Eli Lilly & Co. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
2 hours ago

Altimmune initiated with an Overweight at Barclays

TIPRANKS
·
2 hours ago

Eli Lilly's Jaypirca Gets Approval in Canada for Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia

MT Newswires Live
·
4 hours ago

Why Is Pfizer Stock Rising Tuesday?

Benzinga
·
5 hours ago

Pfizer Is Maintained at Neutral by Cantor Fitzgerald

Dow Jones
·
5 hours ago

Aclaris Hair Loss Drug Shows Faster Results Than Pfizer's Drug

Benzinga_recent_news
·
5 hours ago

Citigroup Maintains Street-High $1,500 Price Target on Eli Lilly Stock (LLY)

TIPRANKS
·
7 hours ago

Amgen Advances Teprotumumab Program With Completed Phase 1 Study in Healthy Chinese Volunteers

TIPRANKS
·
7 hours ago

Eli Lilly’s Pirtobrutinib Trial Completion Signals Next Phase in the BTK Inhibitor Race

TIPRANKS
·
7 hours ago

Moderately bullish activity in Pfizer with shares up 2.14%

TIPRANKS
·
Yesterday